Vimta Labs Ltd

NSE: VIMTALABS · BSE: 524394 · Healthcare · 28 announcements

Share price: ₹570.05
Market cap: ₹2,548 Cr
Revenue (annual): ₹407.3 Cr
Net profit (annual): ₹77.51 Cr
P/E (TTM): 32.0×Sector 53.1×
Promoter holding: 35.67%-0.18% QoQ
FII holding: 4.41%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 3 Employee Stock Options 3 Results Update 2 Other Announcement 2 Management Change 2 Dividend 2 Board Meeting Date 2 Annual General Meeting 2 Price Movement Clarification 1 Debt & Borrowing 1 Credit Rating 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

20 Jul 2026 15:24 IST BSE

Results Update

Vimta Labs Results Update

Vimta Labs announced Q1 FY27 results with total income of ₹112.90 Crore. The company reported a PAT of ₹21.00 Crore for the quarter.

Value: ₹112.9 Cr

Read the filing ↗

6 May 2026 16:38 IST NSE

Results Update

Vimta Labs Results Update

Vimta Labs Limited reported a 19.5% YoY revenue growth for FY26, reaching ₹416.3 Crore. The company achieved its highest-ever quarterly revenue of ₹112.0 Crore in Q4 FY26. Full-year EBITDA margins stood at 35.8% with a PAT margin of 18.6%, driven by strong performance in Pharma and Food divisions.

Value: ₹416.3 Cr

Read the filing ↗